References
- Albery IP, Strang J, Gossop M, Griffiths P. 2000. Illicit drugs and driving: prevalence, beliefs and accident involvement among a cohort of current out-of-treatment drug users. Drug Alcohol Depend. 58:197–204.
- Anglin MD, Almog IJ, Fisher DG, Peters KR. 1989. Alcohol use by heroin addicts: Evidence for an inverse relationship. A study of methadone maintenance and drug-free treatment samples. Am J Drug Alcohol Abuse. 15:191–207.
- Dale-Perera A, Goulão J, Stöver H. 2012. Quality of care provided to patients receiving opioid maintenance treatment in Europe. Heroin Addict Rel Cl. 14:23–38.
- Darke S. 1998. Self-report among injecting drug users: a review. Drug Alcohol Depend. 51:253–263.
- Davies JB, Baker R. 1987. The impact of self-presentation and interviewer bias effects on self-reported heroin use. Br J Addict. 82:907–912.
- Davis WR, Johnson BD. 2007. Prescription opioid use, misuse, and diversion among street drug users in New York City. Drug Alcohol Depend. 92:267–276.
- Duffy P, Baldwin H. 2012. The nature of methadone diversion in England: a Merseyside case study. Harm Reduct J. 9:3.
- El-Bassel N, Schilling RF, Turnbull JE, Su KH. 2006. Correlates of alcohol use among methadone patients. Alcohol Clin Exp Res. 17:681–686.
- Farrington DP. 2001. What has been learned from self-reports about criminal careers and the causes of offending? Report to Home Office. Cambridge: Institute of Criminology.
- Gossop M. 1995. Chasing the dragon: research into heroin smoking in Britain. Eur Addict Res. 1:42–49.
- Griffiths P, Gossop M, Povis B, Strang J. 1993. Reaching hidden populations of drug users by privileged access interviewers: methodological and practical issues. Addiction. 88:1617–1626.
- Griffiths P, Gossop M, Wickenden S, Dunworth J, Harris K, Lloyd C. 1997. A transcultural pattern of drug use: Qat (khat) in the UK. Br J Psychiatry. 170:281–284.
- Hughes P. 1977. Behind the wall of respect: community experiments in heroin addiction control. Chicago, IL: University of Chicago Press.
- Humeniuk R, Ali R, McGregor C, Darke S. 2003. Prevalence and correlates of intravenous methadone syrup administration in Adelaide, Australia. Addiction. 98:413–418.
- Håkansson A, Medvedeo A, Andersson M, Berglund M. 2007. Buprenorphine misuse among heroin and amphetamine users in Malmö, Sweden: purpose of misuse and route of administration. Eur Addict Res. 13:207–215.
- Johnson B. 2011. Metadon och buprenorfin – attraktiva på gatan och utanför vården. Läkartidningen. 108:2309–2311.
- Johnson B, Richert T. 2014 Diversion of methadone and buprenorphine from opioid substitution treatment – a staff perspective. J Psychoactive Drugs. 46:427–435.
- Johnson B, Richert T. 2015a. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors. Int J Drug Policy. 26:183–190.
- Johnson B, Richert T. 2015b. Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients’ attitudes and norms. J Subst Abuse Treat. 54:50–55.
- Johnson TP, Fendrich M, Shaligram C, Garcy A, Gillespie S. 2000. An evaluation of the effects of interviewer characteristics in an RDD telephone survey of drug use. J Drug Issues. 30:77–102.
- Krumpal I. 2013. Determinants of social desirability bias in sensitive surveys: a literature review. Qual Quant. 47:2025–2047.
- Kuebler D, Hausser D. 1997. The Swiss hidden population study: practical and methodological aspects of data collection by privileged access interviewers. Addiction. 92:325–334.
- Lauzon P, Vincelette J, Bruneau J, Lamothe F, Lachance N, Brabant M, Soto J. 2002. Illicit use of methadone among IV drug users in Montreal. J Subst Abuse Treat. 11:457–461.
- Magura S. 2010. Validating self-reports of illegal drug use to evaluate national drug control policy: a reanalysis. Eval Program Plann. 33:234–237.
- Obadia Y, Perrin V, Feroini I, Vlahov D, Moatti JP. 2001. Injecting misuse of buprenorphine among French drug users. Addiction. 96:267–272.
- Platt L, Wall M, Rhodes T, Judd A, Hickman M, Johnson LG, Renton A, Bobrova N, Sarang A. 2006. Methods to recruit hard-to-reach groups: comparing two chain referral sampling methods of recruiting injecting drug users across nine studies in Russia and Estonia. J Urban Health. 83:i39–i53.
- Power R. 1994. Some methodological and practical implications of employing drug users as indigenous fieldworkers. In: Boulton M, editor. Challenge and innovation. Methodological advances in social research on HIV/AIDS. London: Taylor Francis.
- Power R. 1995. A model for qualitative action research amongst illicit drug users. Addict Res. 3:165–181.
- Power R, Harkison S. 1993. Accessing hidden populations: the use of indigenous interviewers. In: Aggleton P, Davies P, Hart G, editors. AIDS: facing the second decade. London: The Falmer Press.
- Rhodes T, Platt L, Maximova S, Koshkina E, Latishevskaya N, Hickman M, Renton A, Bobrova N, McDonald T, Parry JV. 2005. Prevalence of HIV, hepatitis C and syphilisamong injecting drug users in Russia: a multi-city study. Addiction. 101:252–266.
- Schmidt CS, Schulte B, Wickert C, Thane K, Kuhn S, Verthein U, Reimer J. 2013. Non-prescribed use of substitution medication among German drug users: prevalence, motives and availability. Int J Drug Policy. 24:e111–e114.
- Schroder KE, Carey MP, Vanable PA. 2003. Methodological challenges in research on sexual risk behavior: II. Accuracy of self-reports. Ann Behav Med. 26:104–123.
- Spunt B, Hunt DE, Lipton DS, Goldsmith DS. 1986. Methadone diversion: a new look. J Drug Issues. 16:569–583.
- Stastny D, Potter M. 1991. Alcohol abuse by patients undergoing methadone treatment programmes. Br J Addict. 86:307–310.
- Stenbacka M, Beck O, Leifman A, Romelsjö A, Helander A. 2007. Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. Drug Alcohol Rev. 26: 55–63.
- Thornberry TP, Krohn MD. 2000. The self-report method for measuring delinquency and crime. In: Duffee D, editor. Measurement and analysis of crime and justice. Washington, DC: The National Institute of Justice.
- Varescon I, Vidal-Trecan G, Nabet N, Boissonnas A. 2002. Buprenorphine abuse: high dose intravenous administration of buprenorphine. Encephale. 28:397–402.
- Vlahov D, O’Driscoll P, Mehta SH, Ompad DC, Gern R, Galai N, Kirk GD. 2007. Risk factors for methadone outside treatment programs: implications for HIV treatment among injection drug users. Addiction. 102: 771–777.
- Webb EJ. 1981 Nonreactive measures in the social sciences. Boston, MA: Houghton Mifflin.
- Wiebel WW. 1988. Combining ethnographic and epidemiologic methods for targeted AIDS interventions: the Chicago model. In: Battjes RJ, Pickens RW, editors. Needle-sharing among intravenous drug abusers: National and international perspective. NIDA Research Monograph 80.
- Winstock AR, Lea T. 2010. Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia. Subst Use Misuse. 45:240–252.
- Winstock AR, Lea T, Sheridan J. 2008. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. Int J Drug Policy. 19:450–458.
- Williams RJ, Nowatzki N. 2005. Validity of adolescent self-report of substance use. Subst Use Misuse. 40:299–311.
- Yokell MA, Zaller ND, Green TC, Rich JD. 2011. Buprenorphine and buprenorphine/naloxone diversion, misuse, and illicit use: an international review. Curr Drug Abuse Rev. 4:28–41.